Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet. 2005;365(9476):2041–54.
Chen Y-P, Chan ATC, Le Q-T, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80.
Zou X, You R, Liu H, He YX, Xie GF, Xie ZH, et al. Establishment and validation of M1 stage subdivisions for de novo metastatic nasopharyngeal carcinoma to better predict prognosis and guide treatment. Eur J Cancer. 2017;77:117–26.
Bossi P, Chan AT, Licitra L, Trama A, Orlandi E, Hui EP, et al. Nasopharyngeal carcinoma: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up(dagger). Ann Oncol. 2021;32(4):452–65.
You R, Liu YP, Huang PY, Zou X, Sun R, He YX, et al. Efficacy and safety of Locoregional radiotherapy with chemotherapy vs chemotherapy alone in De novo metastatic nasopharyngeal carcinoma: a multicenter phase 3 randomized clinical trial. JAMA Oncol. 2020;6(9):1345–52.
Khot A, Love C, Garg MK, Haigentz M Jr. Long-term disease control in a patient with recurrent bone-only Oligometastatic nasopharyngeal carcinoma. J Clin Oncol. 2016;34(4):e25–6.
Lim A, Corry J, Lau E, Rischin D. Prolonged remission in a patient with nasopharyngeal carcinoma with a solitary bone metastasis. J Clin Oncol. 2011;29(6):e135–7.
Cao X, Han Y, He L, Xiang J, Wen Z. Risk subset of the survival for nasopharyngeal carcinoma patients with bone metastases: who will benefit from combined treatment? Oral Oncol. 2011;47(8):747–52.
Li XY, Jia GD, Sun XS, Guo SS, Liu LT, Liu SL, et al. Intensive local radiotherapy is associated with better local control and prolonged survival in bone-metastatic nasopharyngeal carcinoma patients. Front Oncol. 2020;10:378.
Sun XS, Liang YJ, Liu SL, Chen QY, Guo SS, Wen YF, et al. Subdivision of nasopharyngeal carcinoma patients with bone-only metastasis at diagnosis for prediction of survival and treatment guidance. Cancer Res Treat. 2019;51(4):1259–68.
Nong S, Pan X, Chen K, Li Y, Zhu X. Therapeutic effect of chemotherapy cycle in nasopharyngeal carcinoma (NPC) patients who developed bone-only metastasis. Med Sci Monit. 2020;26:e922244.
Lin C, Lin S, Guo Q-J, Zong J-F, Lu T-Z, Lin N, et al. Systemic immune-inflammation index as a prognostic marker in patients with newly diagnosed metastatic nasopharyngeal carcinoma: a propensity score-matched study. Transl Cancer Res. 2019;8(5):2089–98.
Xu H, Lu L, Lu T, Xu Y, Zong J, Huang C, et al. Identifying the optimal candidates for locoregional radiation therapy in patients with de novo metastatic nasopharyngeal carcinoma. Head Neck. 2021.undefined(undefined). https://doi.org/10.1002/hed.26726.
Li WZ, Lv SH, Liu GY, Liang H, Guo X, Lv X, et al. Development of a prognostic model to identify the suitable definitive radiation therapy candidates in de novo metastatic nasopharyngeal carcinoma: a real-world study. Int J Radiat Oncol Biol Phys. 2021;109(1):120–30.
Yang JH, Sun XS, Xiao BB, Liu LT, Guo SS, Liang JD, et al. Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy. BMC Cancer. 2021;21(1):534.
Liao W, He J, Gou Q, Duan B, Ai P, Liu L, et al. Local treatment of metastases plus systemic chemotherapy on overall survival of patients with metastatic nasopharyngeal carcinoma. Head Neck. 2021;43(8):2423–33.
Tian YH, Zou WH, Xiao WW, Zeng L, Yuan X, Bai L, et al. Oligometastases in AJCC stage IVc nasopharyngeal carcinoma: a subset with better overall survival. Head Neck. 2016;38(8):1152–7.
Zheng W, Zong J, Huang C, Chen J, Wu J, Chen C, et al. Multimodality treatment may improve the survival rate of patients with metastatic nasopharyngeal carcinoma with good performance status. PLoS One. 2016;11(1):e0146771.
Sun XS, Liang YJ, Chen QY, Guo SS, Liu LT, Sun R, et al. Optimizing the treatment pattern for De novo metastatic nasopharyngeal carcinoma patients: a large-scale retrospective cohort study. Front Oncol. 2020;10:543646.
Zeng L, Tian YM, Huang Y, Sun XM, Wang FH, Deng XW, et al. Retrospective analysis of 234 nasopharyngeal carcinoma patients with distant metastasis at initial diagnosis: therapeutic approaches and prognostic factors. PLoS One. 2014;9(9):e108070.
Chen MY, Jiang R, Guo L, Zou X, Liu Q, Sun R, et al. Locoregional radiotherapy in patients with distant metastases of nasopharyngeal carcinoma at diagnosis. Chin J Cancer. 2013;32(11):604–13.
Tian YM, Zeng L, Wang FH, Liu S, Guan Y, Lu TX, et al. Prognostic factors in nasopharyngeal carcinoma with synchronous liver metastasis: a retrospective study for the management of treatment. Radiat Oncol. 2013;8:272.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.